DCVC H1 HA mRNA-LNP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DCVC H1 HA mRNA-LNP, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults [Phase 1]